Pomegra
Swedish legal AI startup Legora raised a €489M Series E led by Atreides Management at a €7.8B valuation, six weeks after rival Harvey's $550M round.
Key Takeaways
- Legora raised $550M (€489M) in a Series E at an $8.8B (€7.8B) post-money valuation, led by Atreides Management.
- The valuation is up from $5.55B in March 2026 and $1.8B in October 2025.
- Annual recurring revenue passed $200M, implying roughly 44x ARR at the new price.
Lead
Legora, the Stockholm-founded legal AI company, announced a €489M ($550M) Series E on October 22, 2026, at a post-money valuation of €7.8B ($8.8B). Atreides Management led the round. New investors include Baron Capital, Capital Group, Fidelity Management & Research Company, Glade Brook Capital Partners and J.P. Morgan. Existing backers Accel, Benchmark and General Catalyst also took part.
The company has now raised about $1.4B since its 2023 founding. CEO and co-founder Max Junestrand said the opportunity in legal is "enormous" and that the company is "still early."
What Is Legora and What Does It Sell?
Legora sells an agentic work platform for lawyers, meaning software that carries out multi-step legal tasks such as drafting, reviewing and research, rather than only answering questions. It counts more than 140,000 legal professionals across more than 2,400 law firms and in-house teams.
The product competes directly with Harvey, the US market leader. Both companies launched identically named "Intake" products on the same day, aimed at helping in-house legal teams manage incoming workflow requests. The overlap shows how closely the two roadmaps now track each other.
How Fast Has the Valuation Moved?
The valuation has risen about 59% in under eight months. Legora raised a $150M Series C at $1.8B in October 2025. It then closed a $550M Series D led by Accel at $5.55B in March 2026, and the new round lifts that figure to $8.8B.
The Series E matches the Series D in size to the dollar. That points to investors paying a higher price for the same amount of capital, not a bigger bet in absolute terms. It also suggests the company is raising on a schedule set by demand from investors, not by cash need.
Does the Revenue Justify the Price?
At more than $200M in ARR, the $8.8B valuation works out to roughly 44 times recurring revenue. That is a steep multiple, though the growth behind it is steep too. Legora went from $1M to $100M in ARR in less than 18 months, and the next $100M took less than six months.
The multiple rests on the assumption that growth holds. Law firm contracts are typically annual, seat-based and sold to a conservative buyer, which gives some revenue visibility. The risk is price pressure. If Harvey and Legora keep matching each other's features, discounting for large firms could compress the margins that a 44x multiple assumes.
Where Does Legora Stand Against Harvey?
Legora trails Harvey on valuation by a wide margin. Harvey raised $550M at a $15.5B valuation in September 2026, about 1.76 times Legora's new figure. Both companies have now raised the same $550M amount in their latest rounds, and Legora closed its round roughly six weeks after Harvey.
The investor mix points to a late-stage shift. Atreides, Baron, Capital Group and Fidelity are crossover and mutual fund investors, not early-stage venture firms. Their presence signals that legal AI is being underwritten as a durable software category with a path to public markets, not only as a venture bet. It also means the next round will face public-market style scrutiny of retention and gross margin.
What Comes Next for Legal AI Funding?
Expect the capital to go toward US expansion, product breadth and hiring, the same priorities behind the March round, which coincided with new offices in Houston and Chicago. The company did not specify a detailed allocation of the new funds.
Two scenarios stand out. In the first, the market supports two scaled leaders, each growing into its valuation as large law firms and corporate legal departments buy from more than one vendor. In the second, one platform consolidates share and the other is forced into a price war or an acquisition. The size of both companies' recent rounds gives each room to avoid the second outcome for now.
Law firm adoption is the variable to watch. Partners billing by the hour have a mixed incentive to adopt tools that shorten the work, which is why in-house teams, the target of both "Intake" products, may be the faster-growing segment.
Outlook
Legora has gone from a $1.8B to an $8.8B valuation in about a year, backed by ARR above $200M and a new round led by a crossover investor. The gap to Harvey remains large, and the pricing power of both companies will be tested as their products converge. The next milestones are ARR growth through 2027 and whether either company can show margins that support a multiple above 40x revenue.
